Here's why the EMvision share price surged 8% on Wednesday

Investors appear happy about an agreement EMvision has struck with tech company Keysight Technologies.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • EMvision shares are racing higher today following a company update
  • The company has entered into a strategic agreement with a long-term partner Keysight Technologies
  • In the last 12 months the EMvision share price has fallen more than 38%

The EMvision Medical Devices Ltd (ASX: EMV) share price has emerged from a trading halt on Wednesday morning, and shot 8% into the green.

Prior to their halt, EMVision shares closed at $1.94. Upon returning to trade, they have been sitting in the green amid the release of a company announcement. At the time of writing, EMvision shares are swapping hands at $2.05.

A guy wearing glasses tries to show off his muscles.

Image source: Getty Images

What did EMVision announce?

The company advised it has entered into an original equipment manufacturer (OEM) agreement with Keysight Technologies Inc (NYSE: KEYS).

According to the release, "Keysight is the world leader in radiofrequency (RF) test and measurement technology". Specifically, the company signed its agreement with Keysight's Australian subsidiary.

Under the agreement, EMvision will receive exclusive supply for 'fast sweep' features in the vector network analyser (VNA).

For reference, EMvision says the VNA is a custom solution developed in collaboration with Keysight.

"The VNA is a high performance, lower component count, miniaturised module responsible for accurate signal measurement," states the release.

"The custom VNA represents a strategic investment by Keysight into the electromagnetic imaging sector."

Regarding the announcement, EMvision CEO Dr Ron Weinberger says the collaboration "has been first class".

This Agreement recognises the roles that both parties have played in the development of the bespoke VNA over a period of 3 years. I would like to thank the Keysight team for their concerted work in developing a best-of-breed solution for EMvision and look forward to the commercial phase of our relationship.

Noteworthy is that Keysight is not a medical device manufacturer. However, it does possess "the strongest portfolio of Vector Network Analysers (VNA), which are core to the sensors that are being used inside EMvision's portable brain scanner," says the company.

The agreement builds on a relationship that spawned back in 2019. Then, the pair entered into a strategic collaboration to develop "custom healthcare-focused VNA solutions".

EMvision share price snapshot

In the last 12 months the EMvision share price has fallen more than 38%. Meanwhile, it is 23.5% in the red since trading resumed this year.

Following this announcement, shares have bounced from a low point and are tracking back towards monthly highs.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended EMvision Medical Devices Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

a man wearing spectacles has a satisfied look on his face as he appears within a graphic image of graphs, computer code and technology related symbols while he concentrates on a computer screen
Technology Shares

Top ASX 200 tech shares to buy right now: Morgans

It’s time to jump on some leading players in the tech sector, according to one broker.

Read more »

A young woman sits on her lounge looking pleasantly surprised at what she's seeing on her laptop screen as she reads about the South32 share price
Technology Shares

These ASX tech shares are buys: Goldman Sachs

Goldman Sachs speaks very highly about these tech shares.

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Technology Shares

Xero share price dips 3% amid Silicon Valley Bank fallout

Xero has been caught up in the Silicon Valley Bank collapse.

Read more »

A worried man holds his head in his hands
Technology Shares

These ASX tech shares have exposure to the Silicon Valley Bank collapse

The second-largest banking collapse in US history occurred last week.

Read more »

asx share price resignation represented by man kicking miniature man through the air
Technology Shares

Novonix shares will soon be booted out of the ASX 200. What might this mean for investors?

ASX 200 share Novonix will soon be just an All Ords share.

Read more »

Technology Shares

Is the new leaner, meaner Xero stock a buy right now?

Is this tech stock a buy after announcing major cost reductions?

Read more »

A young woman with her mouth open and her hands out showing surprise and delight as uranium share prices skyrocket
Technology Shares

Why is the Xero share price racing 11% higher today?

Investors have been fighting to get hold of Xero's shares on Thursday.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Technology Shares

The ASX 200 tech shares I'd be thrilled to buy at a 20% discount

I’d love to go shopping for these tech names if they heavily dipped.

Read more »